中间型至渗出型年龄相关性黄斑变性十年进展及危险因素:Bundang AMD队列研究报告1
该回顾性观察队列研究纳入418例(632眼)50岁及以上中间型AMD患者,评估10年内进展为渗出型AMD的累积发病率并分析遗传与环境影响因素。结果显示2、5、10年累积发病率分别为5.6%、14.8%、28.4%,年龄、AMD家族史、对侧眼已有渗出型AMD及ARMS2 rs10490924与进展正相关,规律饮用绿茶与进展减少相关。
要点
- 中间型AMD进展为渗出型的10年累积发病率为28.4%,年进展率约2.8%。
- 年龄、AMD家族史、对侧眼渗出型AMD及ARMS2 rs10490924是进展危险因素。
- 规律饮用绿茶与渗出型改变减少相关(HR 0.632)。
核心结论
- 韩国人群中中间型AMD进展为渗出型的年进展率约2.8%,与白人相当。
- 绿茶摄入可能是可改变的保护因素。
研究设计与样本
- 回顾性观察队列研究,纳入632眼(418例,年龄≥50岁)中间型AMD患者。
- 通过基线及每年随访的彩色眼底照相和OCT评估渗出型AMD发生。
- 通过问卷获取生活方式与饮食习惯,并分析CFH rs800292、rs1061170及ARMS2 rs10490924基因分型。
- 采用Kaplan-Meier分析累积发病率,Cox回归评估影响因素。
主要发现
- 平均随访3.99±2.85年,2、5、10年进展为渗出型AMD的累积发病率分别为5.6%、14.8%、28.4%。
关键数值与推荐
- 中间型AMD进展为渗出型的累积发病率:2年5.6%、5年14.8%、10年28.4%。
临床怎么用
- 对中间型AMD患者,尤其高龄、有AMD家族史或对侧眼已渗出者,应加强随访监测。
- ARMS2 rs10490924携带者可能需更密切观察。
- 绿茶摄入可作为潜在可改变的保护因素进行讨论,但需进一步验证。
局限性
- 回顾性观察设计,可能存在残余混杂。
- 平均随访3.99±2.85年,短于10年,10年数据基于Kaplan-Meier外推。
- 单一人群(韩国),外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated the 10-year incidence of progression from intermediate to exudative age-related macular degeneration (AMD) and identified genetic and environmental factors influencing that progression in the Korean population. DESIGN: Retrospective, observational cohort study. METHODS: In total, 632 eyes of 418 patients (age: ≥50 years) with intermediate AMD were enrolled. The incidence of exudative AMD was assessed from color fundus photographs and optical coherence tomography images obtained at baseline and during annual visits. Data regarding lifestyle variables and dietary habits were acquired through comprehensive questionnaires. Genotyping data concerning 3 single nucleotide polymorphisms (SNPs), rs800292 and rs1061170 in the CFH gene and rs10490924 in ARMS2 were also analyzed. The cumulative incidence of exudative changes was estimated using Kaplan-Meier analysis. Associated influential factors were evaluated using univariate and multivariate Cox regression models. RESULTS: The mean follow-up period was 3.99 ± 2.85 years. The cumulative incidence of progression to exudative AMD was 5.6%, 14.8%, and 28.4% at 2, 5, and 10 years, respectively. Multivariate Cox analysis showed that age (hazard ratio [HR]: 1.041; P = .0393), family history of AMD (HR: 3.175; P = .0184), and pre-existing exudative AMD in the fellow eye (HR: 3.186; P = 5.31 × 10-5) were positively associated with exudative changes. Regular intake of green tea (HR: 0.632; P = .0475) was associated with a decrease in exudative changes. The ARMS2 SNP rs10490924 (HR: 1.482; P = .0185) showed a significant association with AMD progression. CONCLUSIONS: The annual progression rate from intermediate to exudative AMD in the Korean population is approximately 2.8%, which is comparable with that for whites. Intake of green tea may be a modifiable protective factor against exudative changes.
引用
- Joo K, Mun YS, Park SJ, et al. Ten-Year Progression From Intermediate to Exudative Age-Related Macular Degeneration and Risk Factors: Bundang AMD Cohort Study Report 1. Am J Ophthalmol. 2020. PMID: 33279454. doi:10.1016/j.ajo.2020.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。